Driehaus Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Driehaus Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,275	Closed	-$467K	–	637
2016 Q2	$467K	Sell	3,275 -8	-0.2%	-$1.17K	0.02%	439
2016 Q1	$422K	Buy	+3,283	New	+$388K	0.01%	473
2015 Q3	–	Sell	-10,526	Closed	-$2.54M	–	636
2015 Q2	$2.54M	Sell	10,526 -25,369	-71%	-$6.76M	0.09%	294
2015 Q1	$10.1M	Buy	+35,895	New	+$7.77M	0.35%	65
2014 Q4	–	Sell	-21,119	Closed	-$5M	–	614
2014 Q3	$5M	Sell	21,119 -20,830	-50%	-$5.31M	0.19%	143
2014 Q2	$9.93M	Sell	41,949 -5,187	-11%	-$1.37M	0.32%	70
2014 Q1	$15.5M	Buy	47,136 +12,240	+35%	+$4.13M	0.49%	44
2013 Q4	$2.38M	Buy	+34,896	New	+$2.02M	0.09%	280

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Driehaus Capital Management's ICPT Position: Q3 2016 in Review

Driehaus Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2016, closing a stake of 3,275 shares — an estimated $467K sold.

Driehaus Capital Management first reported a position in ICPT in Q4 2013 and held it in 8 quarters. The position peaked at $15.5M in Q1 2014. 172 funds tracked by Wall St. Rank hold ICPT as of Q3 2016.

Driehaus Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Driehaus Capital Management sold 3,275 Intercept Pharmaceuticals, Inc. shares in Q3 2016, an estimated $467K.
Driehaus Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
Driehaus Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $15.5M in Q1 2014.
172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2016.

Based on Driehaus Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.